Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CACNA2D1 | P54289 | 6/20 | 0.61 |
| ▸ | CACNB1 | Q02641 | 6/20 | 0.61 |
| ▸ | CACNA1B | Q00975 | 5/20 | 0.61 |
| ▸ | CACNA1C | Q13936 | 3/20 | 0.61 |
| ▸ | CACNA1G | O43497 | 3/20 | 0.61 |
| ▸ | CACNA1A | O00555 | 1/20 | 0.60 |
| ▸ | MGLL | Q99685 | 3/20 | 0.57 |
| ▸ | ABHD6 | Q9BV23 | 1/20 | 0.57 |
| ▸ | TACR3 | P29371 | 1/20 | 0.55 |
| ▸ | GPX4 | P36969 | 1/20 | 0.54 |
| ▸ | HRH1 | P35367 | 3/20 | 0.53 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.53 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.53 |
| ▸ | DRD3 | P35462 | 2/20 | 0.53 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.53 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.53 |
| ▸ | HRH2 | P25021 | 1/20 | 0.53 |
| ▸ | HTR2A | P28223 | 1/20 | 0.53 |
| ▸ | HTR2B | P41595 | 1/20 | 0.53 |
| ▸ | TEK | Q02763 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL588070 | 1.00 | CACNA2D1 (0.61) | CACNA2D1CACNB1CACNA1BCACNA1CCACNA1G | |
| SCHEMBL7662352 | 0.85 | CACNA2D1 (0.64) | CACNA2D1CACNB1CACNA1BCACNA1CCACNA1G | |
| SCHEMBL13309487 | 0.81 | CACNA2D1 (0.67) | CACNA2D1CACNB1CACNA1BCACNA1CCACNA1G | |
| SCHEMBL5688541 | 0.81 | CACNA2D1 (0.60) | CACNA2D1CACNB1CACNA1BCACNA1CCACNA1G | |
| SCHEMBL12203725 | 0.80 | MGLL (0.84) | CACNA2D1CACNB1CACNA1BCACNA1CCACNA1G | |
| SCHEMBL4649907 | 0.78 | MGLL (0.62) | CACNA2D1CACNB1CACNA1BCACNA1CCACNA1G | |
| SCHEMBL7665618 | 0.78 | NPC1 (0.78) | CACNA2D1CACNB1CACNA1BCACNA1CCACNA1G | |
| SCHEMBL13309468 | 0.77 | KMT2A (0.82) | CACNA2D1CACNB1CACNA1BCACNA1CCACNA1G | |
| SCHEMBL16769444 | 0.77 | KMT2A (0.82) | CACNA2D1CACNB1CACNA1BCACNA1CCACNA1G | |
| SCHEMBL5268519 | 0.76 | CACNA2D1 (1.00) | CACNA2D1CACNB1CACNA1BCACNA1CCACNA1G |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7851627-B2 | Optically active carbamates, process for preparation thereof and use thereof as pharmaceutical intermediates | EGIS GYOGYSZERGYAR NYILVANOSAN MUKODO RESZVENYTARSASAG (HU) | 2010-12-14 | — | — | US | claimed |
| US-20090221823-A1 | OPTICALLY ACTIVE CARBAMATES, PROCESS FOR PREPARATION THEREOF AND USE THEREOF AS PHARMACEUTICAL INTERMEDIATES | EGIS GYOGYSZERGYAR NYILVANOSAN MUKODO RESZVENYTARSASAG (HU) | 2009-09-03 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090221823-A1 | OPTICALLY ACTIVE CARBAMATES, PROCESS FOR PREPARATION THEREOF AND USE THEREOF AS PHARMACEUTICAL INTERMEDIATES | HRH4, HRH1, HRH2 | CACNA2D1 1056/4885CACNB1 2856/4885CACNA1B 1411/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.